It must be noted, however, that the biomarker levels were significantly more elevated in patients with PDAC compared to patients with non-neoplastic conditions, as depicted in Figure 6C,D, with two exceptions: pancreatitis patients had high levels of LAMC2 that were similar to levels in PDAC patients, and PTX3 was already high in IPMN patients. This evidence concerns the gene LAMC2 and pancreatitis.